Showing results (111-120 of 14,086) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.Gynecologic Oncology|December 25, 2010
Examining the effect of minority status and neighborhood characteristics on cervical cancer survival outcomesJung-won Lim, Kimlin T Ashing-GiwaGynecologic Oncology|January 8, 2011
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer modelKerri S Bevis, Lacey R McNally, Jeffery C Sellers, et al.Gynecologic Oncology|January 8, 2011
Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literatureUmit Ince, Ozlem Aydin, Onder PekerGynecologic Oncology|January 18, 2011
Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detectionJ N McAlpine, S El Hallani, S F Lam, et al.Gynecologic Oncology|September 30, 2010
New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosisS van der Steen, H P van de Nieuwenhof, L Massuger, et al.Gynecologic Oncology|May 1, 1991
Role of induction chemotherapy in invasive cervical cancerT K Park, D H Choi, S N Kim, et al.Gynecologic Oncology|May 1, 1991
Cystotomy--for facilitation of optimal resection of adherent pelvic tumorsG Ben-Baruch, E Schiff, E Sivan, et al.Gynecologic Oncology|May 1, 1991
Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazineS R Simon, S E Wang, M Uhl, et al.Gynecologic Oncology|June 12, 2010
Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancerEi-ichiro Tominaga, Hiroshi Tsuda, Tokuzo Arao, et al.Pageof 1,409